The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Cortical Cholinergic Denervation Elicits Vascular Aβ Deposition
Abstract
A bstract:Selective destruction of the cholinergic nucleus basalis magnocellularis (nbm) in the rabbit by the p75 neurotrophin receptor (NTR) immunoglobulin G (IgG) complexed to the toxin saporin leads to the deposition of amyloid‐beta (Aβ) in and around cerebral blood vessels. In some instances, the perivascular Aβ resemble the diffuse deposits observed in Alzheimer's disease (AD). We propose that cortical cholinergic deprivation results, among other perturbations, in the loss of vasodilation mediated by acetylcholine. In addition to a dysfunctional cerebral blood flow, alterations in vascular chemistry affecting endothelial and smooth muscle cells may result in cerebral hypoperfusion and a breached blood‐brain barrier (BBB). The selective removal of the rabbit nbm and Aβ accumulation may serve as an important nontransgenic, and more physiological, model for the testing of pharmacological and immunological agents designed to control the deposition and the deleterious effects of Aβ in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The mechanism by which anticholinergic medications might contribute to dementia risk is biologically plausible.
“The mechanism by which anticholinergic medications might contribute to dementia risk has not been elucidated; however, a few lines of evidence suggest that it is biologically plausible.”
From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [40]
In animal models, reduced cholinergic transmission via atropine or cortical cholinergic denervation increased amyloid beta concentrations.
“Moreover, in animal models, reduced cholinergic transmission via atropine or cortical cholinergic denervation increased amyloid beta concentrations.38-40”
From Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study (2015) · cites this paper as [40]
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau
Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418
Dietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895
Nitric Oxide Synthase Activity Is Elevated in Brain Microvessels in Alzheimer′s Disease
Dorheim, M. A., Tracey, W. R., Pollock, J. S., & Grammas, P. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2716 · Cited by 216
Flagged first, then by citations
Research works printed but not linked: 37
- 10.1093/brain/87.2.307 · DOI
- Terry R.D., 1964, Ultrastructural studies in Alzheimer's presenile dementia, Am. J. Pathol., 44, 269
- 10.1046/j.1471-4159.1996.67020723.x · DOI
- 10.3109/01913129409023202 · DOI
- 10.3109/07853898909149193 · DOI
- 10.1016/0006-8993(93)90021-E · DOI
- 10.1111/j.1749-6632.1997.tb48467.x · DOI
- 10.1016/0197-4580(94)90151-1 · DOI
- 10.1016/0197-4580(95)00048-J · DOI
- 10.1002/ana.410350507 · DOI · Paper page
- Shimohama S., 1986, Biochemical characterization of alpha‐adrenergic receptors in human brain and changes in Alzheimer‐type dementia, J. Neurochem., 47, 1295, 10.1111/j.1471-4159.1986.tb00753.x · DOI
- 10.1016/0304-3940(91)90064-Z · DOI
- 10.1111/j.1749-6632.1997.tb48468.x · DOI
- 10.1073/pnas.90.22.10836 · DOI · Paper page
- 10.1002/ana.410380219 · DOI
- Premkumar D.R., 1996, Apolipoprotein E‐ɛ4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease, Am. J. Pathol., 148, 2083
- 10.1016/S0002-9440(10)65184-X · DOI · Paper page
- 10.1016/0168-0102(92)90071-J · DOI
- Edvinsson L. E.T. Mackenzie & J. McCulloch. 1993. Cerebral Blood Flow and Metabolism. Raven Press. New York. · DOI
- 10.1007/BF00691428 · DOI
- 10.1002/ana.410240210 · DOI · Paper page
- 10.1016/S0165-0270(87)80001-8 · DOI
- 10.1177/34.11.2430009 · DOI
- 10.1111/j.1471-4159.1975.tb11895.x · DOI
- 10.1177/38.11.2212623 · DOI
- 10.1046/j.1471-4159.1998.71062505.x · DOI
- 10.1016/S0306-4522(96)00489-7 · DOI
- Beach T.G., 1998, Neurofibrillary tangles are constant in aging human nucleus basalis, Alzheimer's Reports, 1, 375
- 10.1016/S0140-6736(76)91936-X · DOI · Paper page
- Funato H., 1998, Quantitation of amyloid β‐protein (Aβ) in the cortex during aging and in Alzheimer's disease, Am. J. Pathol., 152, 1633
- 10.1126/science.1411529 · DOI · Paper page
- 10.1016/S0006-8993(98)01174-3 · DOI
- 10.1523/JNEUROSCI.17-02-00516.1997 · DOI · Paper page
- 10.1016/S0140-6736(96)90608-X · DOI · Paper page
- Miller J.W., 1999, Homocysteine and Alzheimer's disease, Nutr. Rev., 57, 126
- 10.1016/S0002-9343(97)00258-1 · DOI
- 10.1006/exnr.1997.6743 · DOI
Cited by
Sorted by citations
Cumulative Use of Strong Anticholinergics and Incident Dementia: A Prospective Cohort Study
Gray, S. L., Anderson, M. L., Dublin, S., Hanlon, J. T., Hubbard, R., Walker, R., Yu, O., Crane, P. K., & Larson, E. B. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.7663 · Cited by 1,111
Targeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Metadata
- Authors
- ROHER, A. E., KUO, Y., POTTER, P. E., EMMERLING, M. R., DURHAM, R. A., WALKER, D. G., SUE, L. I., HONER, W. G., & BEACH, T. G.
- Affiliations
- Banner Sun Health Research Institute (US)
- University of British Columbia (CA)
- Corresponding author
- ROHER, ALEX E.
- Venue
- Annals of the New York Academy of Sciences
- Publisher
- Wiley
- Published
- 2000-04
- Volume
- 903
- Issue
- 1
- Pages
- 366-373
- ISSN
- 0077-8923 (ISSN-L)
- 1749-6632
- OpenAlex
- W2084120977
- Cited by
- 52
- References
- 4
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 5 · 2020: 3 · 2018: 1 · 2017: 3 · 2016: 2 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 1
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of the New York Academy of Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- amyloid-beta deposition, nucleus basalis magnocellularis, cholinergic denervation, saporin, p75 neurotrophin receptor, acetylcholine, vasodilation, cerebral hypoperfusion, blood-brain barrier, Alzheimer's disease model, cerebral blood flow
- MeSH terms
- Saporins, Acetylcholine, Alzheimer Disease, Animals, Antibodies, Monoclonal, Immunotoxins, Blood-Brain Barrier, Cerebral Cortex, Cerebral Ventricles, Cerebrovascular Circulation, Denervation, Immunoglobulin G, Injections, Intraventricular, Functional Laterality, Microcirculation, N-Glycosyl Hydrolases, Plant Proteins, Rabbits, Regional Blood Flow, Amyloid beta-Peptides, Receptors, Nerve Growth Factor, Basal Nucleus of Meynert, Ribosome Inactivating Proteins, Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review